Delivery Order SPE2DB20D1100-SPE2DB24FA8D2

Award Date 3/19/24
Potential Completion Date 4/9/24
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, for the supply of GAMUNEX-C 40 gram/400 ml vials. The contract has a firm fixed price of $9,618.16 and a period of performance through April 23, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) held by AmerisourceBergen with DLA, which has a potential value of up to $999,999,999.00 and extends through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $24,648.20, is for the delivery of GAMUNEX-C 20 gram/200 ml vials. The contract is a firm fixed price type with a period of performance through December 19, 2024. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) held by...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GAMUNEX-C 40 GRAM/400 ML VIAL 400ML, a medical product, with a ceiling value of $55,852.80 and a period of performance running through February 3, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of GAMUNEX-C 1 gram/10 ml vials. The contract has a ceiling value of $2,404.40 and a period of performance ending on August 28, 2024. AmerisourceBergen, a major pharmaceutical distributor, was awarded this firm fixed-price delivery order contract without any set-aside designation. This order is likely part of a larger Indefinite Delivery Contract (IDC) between...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GAMUNEX-C 40 gram/400 ml vials. The firm-fixed-price contract has a total ceiling value of $69,599.48 and a period of performance through October 18, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 between DLA Troop Support Medical and AmerisourceBergen, which serves as a primary vehicle...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation. The contract is for the supply of the pharmaceutical product GAMUNEX-C, a 40 gram/400 ml vial. The delivery order has a ceiling value of $14,427.24 and a period of performance through April 3, 2024. Amerisourcebergen Drug Corp holds an indefinite...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $14,982.10 to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company. The contract is for the supply of GAMUNEX-C 10 gram/100 ml vials with a completion date of February 21, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $24,045.60 firm fixed-price contract is for the delivery of 4,566,102,267 units of the pharmaceutical product GAMUNEX-C 10 GRAM/100 ML VIAL 100ML. The contract has a period of performance through November 5, 2024 and was awarded on October 15, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 between...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of GAMUNEX-C 10 gram/100 ml vial in the amount of $12,022.80. The order is issued under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $24,418.80 and covers the delivery of GAMUNEX-C 10 GRAM/100 ML VIAL 100ML, a pharmaceutical product, to support federal healthcare programs. The contract is a Firm Fixed Price type and has an ultimate completion date of January 24, 2025. It is not designated as a set-aside...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FA8D2
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, to provide 4,564,015,116 units of GAMUNEX-C 10 gram/100 ml vials. The firm fixed price contract has a ceiling value of $14,982.10 and a performance period through April 9, 2024. This delivery order is issued under an indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for AmerisourceBergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract.

Generated 6/18/24, 3:16 PM